Poorly controlled diabetes — not diabetes itself — triples dementia risk, study finds
By
Alicia Lasek
Oct 13, 2021
In the absence of a cure for dementia, prevention is vital, and a new study offers evidence that this can be done through the careful control of diabetes, investigators say.
Diabetes and obesity drugs reduce COVID-19 complications, analysis shows
By
Alicia Lasek
Sep 28, 2021
Diabetes type 2 is linked to severe COVID-19 illness, but a type of drug used to improve glycemic control and weight loss may also reduce complications from the viral disease, a new study finds.
Clinical briefs for Thursday, July 8
By
Alicia Lasek
Jul 08, 2021
New CMS Medicare chief was health system exec, former HHS health reform director … More falls may occur in SNFs after admitting residents with existing cognitive decline: study … New health benefits...
Clinicians urged to check for sleep disturbance in diabetes, a key mortality indicator
By
Alicia Lasek
Jun 14, 2021
Trouble falling or staying asleep is linked to 87% greater odds of death from any cause over the next nine years in people with diabetes, a new study finds. A simple question can help clinicians identify...
After decade of progress, diabetes control loses steam as first-line therapies go underused
By
Alicia Lasek
Jun 11, 2021
Reinvigorating the use of first-line therapies such as statins, metformin, ACE inhibitors or ARB is key to getting care and outcomes back on track, investigators say.
Clinical briefs for Wednesday, June 9
By
Alicia Lasek
Jun 09, 2021
Twist in the FDA’s Alzheimer’s decision: no limits on which patients can get the drug … Biden administration advises changes to policies linked to N95 shortages … Frailty tied to increased mortality...
Prediabetes wreaks havoc on the cardiovascular system, clinicians warned
By
Alicia Lasek
May 06, 2021
Prediabetes may be more destructive to the heart and vascular system than many clinicians realize, nearly doubling the risk of adverse events, according a new study to be presented at next week’s...
Diabetes med Farxiga gets FDA nod as kidney failure treatment; drug cuts risk by 39 percent
By
Alicia Lasek
May 04, 2021
Farxiga, an SGLT2 inhibitor, was found to reduce the risk of worsening renal function or cardiovascular or renal death by 39% in patients with chronic kidney disease — with and without type 2 diabetes.
New diabetes cases linked to COVID-19
By
Alicia Lasek
Feb 03, 2021
Some cases of type 1 and type 2 diabetes are occurring in COVID-19 patients who have no known risk factors or prior health concerns, according to a report.
NSAIDs may raise risk of kidney injury in patients with diabetes
By
Alicia Lasek
Jan 21, 2021
Short-term use of NSAIDs, which include ibuprofen, aspirin and naproxen, is linked to kidney damage and high potassium levels, researchers have found.